Radiopharmaceuticals for cardiac imaging

Journal Article · Sun Dec 01 04:00:00 EST 1985 · Radiol. Clin. North Am.; (United States)

OSTI ID:5808398

Miller, D D; Elmaleh, D R; McKusick, K A; Boucher, C A; Callahan, R J; Strauss, H W

A number of new radiopharmaceuticals have been developed to increase the diagnostic utility of nuclear medicine in cardiac diseases. The radiochemistry and dosimetry of and clinical experience with these new agents are summarized, and are compared with more widely used methods for assessing myocardial perfusion (thallium-201 scintigraphy) and ventricular function (technetium-99m radioangiography). Emerging techniques for the evaluation of myocardial necrosis and metabolism are also presented, with emphasis on the use of radiolabeled antimyosin antibody and fatty acid analogue imaging in ischemic heart disease.

• OSTI ID: 5808398
• Journal Information: Radiol. Clin. North Am.; (United States), Journal Name: Radiol. Clin. North Am.; (United States) Vol. 4; ISSN RCNAA
• Country of Publication: United States
• Language: English

Related Subjects

550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ALDEHYDES
AMINO ACIDS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARBOHYDRATES
CARBOXYLIC ACIDS
CARDIOVASCULAR SYSTEM
CHELATING AGENTS
CHEMISTRY
COMPARATIVE EVALUATIONS
DIAGNOSTIC USES
DRUGS
DTPA
GLUCOSE
HEART
HEXOSES
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MEDICINE
METABOLISM
MONOSACCHARIDES
MUSCLES
MYOCARDIUM
NECROSIS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANIC ACIDS
ORGANIC COMPOUNDS
ORGANS
PATHOLOGICAL CHANGES
RADIOCHEMISTRY
RADIOISOTOPES
RADIOPHARMACEUTICALS
RADIOPROTECTIVE SUBSTANCES
SACCHARIDES
TECHNETIUM 99
TECHNETIUM ISOTOPES
USES
YEARS LIVING RADIOISOTOPES